News - UF Innovate

UF Scientists To Develop AI Technology To Help Growers Assess Crop Damage After Hurricanes

UF researcher Nikolaos Tziolas is developing an AI-powered interactive tool to help farmers assess crop damage after major storms and compare it to previous seasons.

Study: What Makes a Smell Bad?

UF researchers Sarah Sniffen and Dan Wesson have uncovered the mechanisms behind how order acquires emotional significance.

Researchers Lay Groundwork for At-Home Cervical Cancer Screening

UF researchers have led a study that brings us one step closer to developing a simple, at-home test to prevent cervical cancer or detect it early—an advancement with the potential to transform early-stage diagnosis and treatment.

UF-Bred MicroPure Genomics Awarded Competitive NSF Grant

MicroPure Genomics Inc., a revolutionary sample prep technology company with deep University of Florida roots, has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for nearly $1.3 million to conduct research and development on redefining front-end sample preparation for genomic analysis in research and healthcare.

From Classroom to Cosmos: Students Aim To Build Big Things in Space

UF engineers are exploring how to manufacture precision metal structures in orbit using laser technology, in partnership with DARPA and NASA’s Marshall Space Flight Center.

University of Florida Secures Land and Capital Support for Campus in Jacksonville

UF announced that it has secured land and capital support for a new campus in Jacksonville—marking a significant public investment in higher education, research, and economic growth.

Tech Tuesday: University of Florida Lab Using A.I. To Help Diagnose and Improve Patient Treatment

In this week’s Tech Tuesday, UF Innovate highlights Dr. Xiang Zhong and her team in UF’s Department of Industrial and Systems Engineering, who are using artificial intelligence to create digital twins that support critical care.

TuHURA Biosciences Initiates Its Phase 3 Accelerated Approval Trial of IFx-2.0 as an Adjunctive Therapy to Keytruda® (Pembrolizumab) in First Line Treatment for Advanced or Metastatic Merkel Cell Carcinoma

TuHURA Biosciences, formed by CohBar and Morphogenesis, a UF startup, has announced the initiation of its Phase 3 accelerated approval trial of IFx-2.0, TuHURA's lead innate immune agonist, in patients with advanced or metastatic Merkel cell carcinoma (MCC).

UF, Trinity College Team Cracks Micronutrient Mystery That Could Be Key to Brain Health, Cancer Defense

UF researchers co-led a study that has solved a decades-old mystery in human biology: how our bodies absorb a vital micronutrient essential for everything from healthy brain function to cancer defense.

UF Health Researchers Propose AI Model To Predict Mortality in Coronary Artery Disease Patients

UF researchers have led a study proposing an artificial intelligence model to predict long-term mortality in patients with coronary artery disease.

UF News